Valence8 US »

Miragen Therapeutics shares owned by Valence8 US

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Valence8 US from 13F filings

Historical chart of Valence8 US investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Valence8 US consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Valence8 US

Quarter filed Position value Share count Share price at filing
2024-09-30 $298k 13k 22.75

More positions owned by Valence8 US

Ishares Tr Msci Usa Qlt Fct (QUAL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Msci Intl Qualty (IQLT)
Ishares Tr Eafe Value Etf (EFV)
Vanguard Index Fds Value Etf (VTV)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Ishares Tr Msci Uk Etf New (EWU)
Ishares Msci Jpn Etf New (EWJ)
Astrazeneca Sponsored Adr Call Option (AZN)
Select Sector Spdr Tr Sbi Int-utils (XLU)
Amgen Put Option (AMGN)
Soleno Therapeutics (SLNO)
Insmed Com Par $.01 Call Option (INSM)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Bristol Myers Squibb (BMY)

View all positions for Valence8 US

Top funds holding Miragen Therapeutics

FMR
BlackRock
Vanguard Group
VR Adviser
Deep Track Capital
Fairmount Funds Management
Paradigm Biocapital Advisors
Perceptive Advisors
Commodore Capital
Kynam Capital Management
Novo A/S
State Street Corporation
Tang Capital Management
Alliancebernstein
Maverick Capital

View all funds holding Miragen Therapeutics